HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dan Xu Selected Research

Defensins

1/2020Defensins: A Double-Edged Sword in Host Immunity.
12/2019Human Enteric Defensin 5 Promotes Shigella Infection of Macrophages.
10/2019Critical determinants of human neutrophil peptide 1 for enhancing host epithelial adhesion of Shigella flexneri.
1/2018Human Enteric α-Defensin 5 Promotes Shigella Infection by Enhancing Bacterial Adhesion and Invasion.
12/2012Enhanced expression of human β-defensin 2 in peripheral lungs of patients with chronic obstructive pulmonary disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Dan Xu Research Topics

Disease

85Neoplasms (Cancer)
05/2024 - 11/2004
67Inflammation (Inflammations)
04/2024 - 01/2009
41Infections
04/2024 - 04/2004
35Chronic Obstructive Pulmonary Disease (COPD)
04/2024 - 06/2007
26Fibrosis (Cirrhosis)
01/2024 - 08/2011
18COVID-19
01/2024 - 01/2020
17BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
11/2022 - 12/2003
16Obesity
01/2024 - 09/2011
16Leukemia
07/2018 - 04/2003
16Graft vs Host Disease (Graft-Versus-Host Disease)
10/2013 - 11/2003
14Neoplasm Metastasis (Metastasis)
02/2024 - 11/2006
14Pneumonia (Pneumonitis)
05/2023 - 04/2004
13Breast Neoplasms (Breast Cancer)
04/2024 - 11/2004
11Glioma (Gliomas)
04/2024 - 01/2018
11Pain (Aches)
02/2024 - 09/2016
11Carcinogenesis
01/2021 - 12/2008
10Fetal Growth Retardation (Intrauterine Growth Retardation)
03/2024 - 11/2011
10Non-alcoholic Fatty Liver Disease
01/2024 - 09/2011
10Body Weight (Weight, Body)
12/2023 - 06/2012
9Sepsis (Septicemia)
04/2024 - 01/2017
9Hypoxia (Hypoxemia)
01/2024 - 01/2013
9Ischemia
01/2024 - 01/2007
9Hypersensitivity (Allergy)
11/2022 - 01/2013
8Necrosis
12/2023 - 04/2007
8Wounds and Injuries (Trauma)
12/2023 - 07/2008
8Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
08/2023 - 04/2002
8Insulin Resistance
01/2023 - 03/2013
8Lung Neoplasms (Lung Cancer)
01/2023 - 04/2004
8Carcinoma (Carcinomatosis)
07/2022 - 09/2007
7Hemorrhage
12/2023 - 01/2009
7Hyperplasia
12/2023 - 06/2009
7Ischemic Stroke
12/2023 - 03/2010
7Cardiovascular Diseases (Cardiovascular Disease)
03/2023 - 09/2012
7Acute Lung Injury
07/2022 - 09/2012
7Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2022 - 01/2012
7Stroke (Strokes)
11/2021 - 03/2010
6Pancreatitis
04/2024 - 12/2013
6Melanoma (Melanoma, Malignant)
02/2024 - 08/2012
6Asthma (Bronchial Asthma)
01/2024 - 11/2007
6Lung Injury
03/2023 - 03/2009
6Reperfusion Injury
12/2022 - 01/2007
6Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
07/2022 - 09/2012
6Osteoporosis
05/2022 - 11/2012
6Liver Cirrhosis (Hepatic Cirrhosis)
11/2018 - 04/2007
5Bacterial Infections (Bacterial Infection)
01/2024 - 07/2019
5Hypercholesterolemia
12/2023 - 09/2014
5Atherosclerosis
12/2023 - 01/2018
5Liver Diseases (Liver Disease)
03/2023 - 10/2020
5Fetal Weight
12/2022 - 04/2012
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
12/2022 - 11/2019

Drug/Important Bio-Agent (IBA)

65Proteins (Proteins, Gene)FDA Link
04/2024 - 10/2004
36CytokinesIBA
03/2024 - 04/2009
28MicroRNAs (MicroRNA)IBA
01/2024 - 01/2011
23Messenger RNA (mRNA)IBA
01/2023 - 04/2004
19Biomarkers (Surrogate Marker)IBA
04/2024 - 01/2011
19SmokeIBA
01/2023 - 03/2010
18Therapeutic UsesIBA
05/2024 - 11/2002
15Glucose (Dextrose)FDA LinkGeneric
03/2024 - 12/2010
13LipidsIBA
03/2024 - 02/2014
13EnzymesIBA
01/2024 - 03/2006
12Caffeine (No Doz)FDA LinkGeneric
12/2023 - 01/2012
11RNA (Ribonucleic Acid)IBA
04/2024 - 11/2012
11VaccinesIBA
03/2024 - 02/2014
11AntioxidantsIBA
01/2023 - 03/2008
11Peptides (Polypeptides)IBA
01/2021 - 07/2003
11Imatinib Mesylate (Gleevec)FDA Link
05/2016 - 12/2003
10LipopolysaccharidesIBA
01/2024 - 01/2009
10GlucocorticoidsIBA
01/2024 - 01/2018
10EndosulfanIBA
03/2023 - 03/2016
10Interleukin-6 (Interleukin 6)IBA
01/2023 - 01/2015
9Dexamethasone (Maxidex)FDA LinkGeneric
03/2024 - 11/2011
9DNA (Deoxyribonucleic Acid)IBA
01/2023 - 11/2005
8CholesterolIBA
03/2024 - 04/2007
8CateninsIBA
01/2024 - 11/2014
8InflammasomesIBA
11/2023 - 01/2018
8Oxygen (Dioxygen)IBA
10/2023 - 12/2010
8Long Noncoding RNAIBA
03/2023 - 11/2011
8Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2020 - 03/2005
8Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 04/2002
7Retinaldehyde (Retinal)IBA
03/2024 - 09/2004
7Brain-Derived Neurotrophic Factor (BDNF)IBA
02/2024 - 01/2018
7p38 Mitogen-Activated Protein KinasesIBA
01/2020 - 09/2009
6NicotineFDA Link
10/2022 - 05/2013
6AntigensIBA
01/2022 - 01/2008
6C-Reactive ProteinIBA
03/2021 - 01/2015
6Phosphotransferases (Kinase)IBA
11/2020 - 03/2006
6Caspase 3 (Caspase-3)IBA
11/2020 - 03/2005
6MucinsIBA
10/2016 - 06/2007
6Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2013 - 11/2003
5Monoclonal AntibodiesIBA
04/2024 - 10/2006
5COVID-19 VaccinesIBA
03/2024 - 01/2021
5LigandsIBA
12/2023 - 03/2005
5oxidized low density lipoproteinIBA
11/2023 - 09/2012

Therapy/Procedure

71Therapeutics
05/2024 - 09/2003
21Transplantation
05/2024 - 11/2002
19Hematopoietic Stem Cell Transplantation
03/2019 - 04/2003
11Drug Therapy (Chemotherapy)
04/2023 - 11/2009
10Immunotherapy
03/2024 - 01/2019
9Chinese Traditional Medicine (Traditional Chinese Medicine)
04/2024 - 03/2008
8Aftercare (After-Treatment)
12/2023 - 09/2007